Get my own profile
Public access
View all4 articles
4 articles
available
not available
Based on funding mandates
Co-authors
- Gerard MarekGilgamesh PharmaceuticalsVerified email at gilgameshpharmaceutical.com
- Paul L. OrnsteinApollo Drug Discovery Consulting, LLCVerified email at apolloddc.com
- Michael O'NeillHead of Molecular Pathology, Eli Lilly & Co. Ltd.Verified email at lilly.com
- Giuseppe BattagliaDirigente Medico I livello, I.R.C.C.S. I.N.M. Neuromed, Pozzilli (IS)Verified email at neuromed.it
- Professor David JaneProfessor of Chemical Pharmacology, University of BristolVerified email at bristol.ac.uk
- Bruno ValeriaProfessore di Farmacologia, Università Sapienza, RomaVerified email at uniroma1.it
- Philip BeartProfessor of Neuroscience, University of MelbourneVerified email at florey.edu.au
- Harlan ShannonDept of Pediatrics, IU School of MedicineVerified email at iupui.edu
- Gary GilmourCOMPASS PathwaysVerified email at compasspathways.com
- Gregory A. StephensonResearch Advisor, Eli Lilly and Co., Consultant Pharma Form Finders, LLCVerified email at pharmaformfinders.com
- Michael A. RogawskiProfessor of Neurology and Pharmacology, University of California,DavisVerified email at ucdavis.edu
- Christian C. FelderSenior Scientific Fellow, Karuna TherapeuticsVerified email at karunatx.com
- Robert StratfordAdjunct Associate Professor, Indiana University School of MedicineVerified email at iu.edu
- David M. ChenowethProfessor of Chemistry, University of PennsylvaniaVerified email at sas.upenn.edu